WGS — GeneDx Holdings Share News
0.000.00%
- $2.09bn
- $2.06bn
- $427.54m
GeneDx rises after Q3 results beat market estimates
U.S. STOCKS ON THE MOVE-Microsoft, Smithfield Foods, SoFi Technologies
U.S. STOCKS ON THE MOVE-PayPal, Microsoft, SoFi
U.S. STOCKS ON THE MOVE- PayPal, SoFi Technologies, JetBlue Airways
GeneDx rises after Q3 results beat market estimates
Advisory: Alerts on dated news on GeneDx exiting two businesses withdrawn
Brief: GeneDx Holdings Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Genomics firm GeneDx beats Q3 revenue estimates, raises outlook
U.S. RESEARCH ROUNDUP-Block, Morgan Stanley, W R Berkley
Brief: GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx and GenomeDx Testing
Brief: Illumina Constellation Mapped Read Technology Uncovers Hard-To-See Genomic Insights In GeneDx Pilot
Brief: Genedx To Launch Autism Partnership Program To Expand Access To Exome And Genome Testing
Brief: GeneDx Appoints Visionary AI And Precision Medicine Leader Dr. Thomas Fuchs To Board Of Directors
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
Genetic testing firm GeneDx beats Q2 adjusted EPS estimates, raises full-year guidance
Advisory: Alert on GeneDx's Q2 revenue was erroneous and has been withdrawn
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
GeneDx rises after Piper Sandler initiates coverage with 'overweight' rating
U.S. RESEARCH ROUNDUP- Fedex, Omnicom Group, Texas Instruments